Benjamin A. Fisher

5.1k citations

66 papers · 1.6k indexed · h-index 22

Physiology top 5%
Rheumatology top 2%
Immunology top 10%
Oncology top 10%
Surgery top 10%

Co-authors: Francesca Barone Simon Bowman Christopher D. Buckley Andrew Filer Karim Raza Saba Nayar Florian Kollert Joana Campos
Topics: Salivary Gland Disorders and Functions (34 papers)Salivary Gland Tumors Diagnosis and Treatment (12 papers)Systemic Lupus Erythematosus Research (9 papers)
Cited by: Rheumatology Periodontics Physiology
Journals: Proceedings of the National Academy of Sciences The Lancet PLoS ONE
Partner nations: United Kingdom United States Switzerland

In The Last Decade

Benjamin A. Fisher

60 papers receiving 1.6k citations

Peers

Countries citing papers authored by Benjamin A. Fisher

Since Specialization

Citations

This map shows the geographic impact of Benjamin A. Fisher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin A. Fisher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin A. Fisher more than expected).

Fields of papers citing papers by Benjamin A. Fisher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin A. Fisher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin A. Fisher. The network helps show where Benjamin A. Fisher may publish in the future.

Co-authorship network of co-authors of Benjamin A. Fisher

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin A. Fisher. A scholar is included among the top collaborators of Benjamin A. Fisher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin A. Fisher. Benjamin A. Fisher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hormonal risk factors and androgen and glucocorticoid dysregulation in Sjogren’s disease and non-Sjogren’s sicca 2025 ·Lara D. Veeken ·Jason D. Turner,(unknown),Lorna C Gilligan,Valentina Pucino,(unknown),(unknown),Saaeha Rauz,(unknown),Jonathan Higham,Andrea Richards,Rachel M. Brown,(unknown),Angela E. Taylor,Saba Nayar,Benjamin A. Fisher	0
2	Lactate signalling leads to aggregation of immune-inflammatory hotspots and SLC5A12 blockade promotes their resolution 2025 ·Nature Metabolism ·Michelangelo Certo,Elena Pontarini,(unknown),Ronny Schmidt,Jason D. Turner,Davide Lucchesi,(unknown),(unknown),Charlotte G. Smith,Serena Colafrancesco,Joana Campos,Saba Nayar,Christoph Schröder,Benjamin A. Fisher,Fabian Spill,Stefano Bombardieri,Claudio Mauro	1
3	Reliability Exercise of Ultrasound Salivary Glands in Sjögren’s Disease: An International Web Training Initiative 2024 ·Rheumatology and Therapy ·(unknown),Alain Saraux,Guillermo Carvajal Alegria,Dewi Guellec,Gaël Mouterde,(unknown),Daniel Hammenfors,Malin V. Jonsson,Sung‐Eun Choi,(unknown),Alja J. Stel,Benjamin A. Fisher,Mark Maybury,Benedikt Hofauer,Francesco Ferro,Vera Milić,Dana DiRenzo,Valérie Devauchelle‐Pensec,Sandrine Jousse‐Joulin	1
4	Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52‐Week Results From a Randomized, Placebo‐Controlled, Phase 2b Dose‐Ranging Study 2024 ·Arthritis & Rheumatology ·Thomas Dörner,Simon Bowman,Robert I. Fox,Xavier Mariette,Athena Papas,Thomas Grader‐Beck,Benjamin A. Fisher,Filipe Barcelos,Salvatore De Vita,Hendrik Schulze‐Koops,Robert J. Moots,G. Junge,(unknown),Monika Sopala,Alexandre Avraméas,Wen‐Lin Luo,Wolfgang Hueber	3
5	A randomized, double-blind, placebo-controlled, parallel group study on the effects of a cathepsin S inhibitor in primary Sjögren’s syndrome 2023 ·Lara D. Veeken ·Darren Bentley,Benjamin A. Fisher,Francesca Barone,Fabrice A. Kolb,(unknown)	21
6	Examining the biological pathways underlying clinical heterogeneity in Sjogren's syndrome: proteomic and network analysis 2023 ·Annals of the Rheumatic Diseases ·(unknown),Jessica Tarn,John Casement,(unknown),Lauren J Scott,Karl V. Wood,(unknown),Gunnel Nordmark,Valérie Devauchelle‐Pensec,Raphaèle Séror,Benjamin A. Fisher,(unknown),Simon Bowman,Stefano Bombardieri,Dennis Lendrem,Renaud Felten,Jacques‐Eric Gottenberg,Wan‐Fai Ng	9
7	Development and preliminary validation of the Sjögren's Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren's syndrome 2022 ·Annals of the Rheumatic Diseases ·Raphaèle Séror,Gabriel Baron,Marine Camus,Divi Cornec,Élodie Perrodeau,Simon Bowman,Stefano Bombardieri,Hendrika Bootsma,Jacques‐Eric Gottenberg,Benjamin A. Fisher,Wolfgang Hueber,J.A. van Roon,Valérie Devauchelle‐Pensec,P Gergely,Xavier Mariette,Raphaël Porcher,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	42
8	History of tonsillectomy is associated with glandular inflammation in Sjögren’s disease 2022 ·Lara D. Veeken ·Florian Kollert,Valentina Pucino,Saba Nayar,Jason D. Turner,Saaeha Rauz,Andrea Richards,Jonathan Higham,(unknown),Rachel M. Brown,Timothy C. Bates,Simon Bowman,Francesca Barone,Benjamin A. Fisher	2
9	Sjögren’s and non-Sjögren’s sicca share a similar symptom burden but with a distinct symptom-associated proteomic signature 2022 ·RMD Open ·Valentina Pucino,Jason D. Turner,Saba Nayar,Florian Kollert,Saaeha Rauz,Andrea Richards,Jonathan Higham,(unknown),Simon Bowman,Francesca Barone,Benjamin A. Fisher	6
10	CATALYST trial protocol: a multicentre, open-label, phase II, multiarm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults 2021 ·BMJ Open ·Tonny Veenith,Benjamin A. Fisher,Daniel Slade,Anna Rowe,Rowena Sharpe,David Thickett,Tony Whitehouse,Matthew Rowland,James Scriven,Dhruv Parekh,S. Bowden,Joshua Savage,Duncan Richards,Julian Bion,Pamela Kearns,Simon Gates	3
11	Checkpoint Inhibition Reduces the Threshold for Drug-Specific T-Cell Priming and Increases the Incidence of Sulfasalazine Hypersensitivity 2021 ·Toxicological Sciences ·(unknown),Anna Olsson‐Brown,(unknown),Andrew Gibson,Joshua Gardner,José Luis Castrejón-Flores,(unknown),Benjamin A. Fisher,Neil Steven,Catherine J. Betts,Munir Pirmohamed,Xiaoli Meng,Dean J. Naisbitt	27
12	The management of Sjögren’s syndrome: British Society for Rheumatology guideline scope 2020 ·Lara D. Veeken ·Elizabeth Price,Alexander Allen,Saaeha Rauz,Anwar R. Tappuni,Nurhan Sutcliffe,Stefano Bombardieri,Sara Carty,Coziana Ciurtin,(unknown),(unknown),Benjamin A. Fisher,Peter E. Glennon,Katie L. Hackett,Genevieve Larkin,Wan‐Fai Ng,Athimalaipet V Ramanan,Saad M. B. Rassam,Stephen B. Walsh,Simon Bowman	5
13	CXCL13 as biomarker for histological involvement in Sjögren’s syndrome 2019 ·Lara D. Veeken ·Serena Colafrancesco,Roberta Priori,Charlotte G. Smith,Antonina Minniti,Valentina Iannizzotto,Elena Pipi,Davide Lucchesi,Elena Pontarini,Saba Nayar,Joana Campos,(unknown),Massimo Fusconi,Bruna Cerbelli,Carla Giordano,Guido Valesini,Stefano Bombardieri,Benjamin A. Fisher,Francesca Barone	30
14	Management of rheumatic complications of immune checkpoint inhibitor therapy – an oncological perspective 2019 ·Lara D. Veeken ·Neil Steven,Benjamin A. Fisher	21
15	Increased sensitivity of Treg cells from patients with PBC to low dose IL-12 drives their differentiation into IFN-γ secreting cells 2018 ·Journal of Autoimmunity ·Evaggelia Liaskou,Samita R. Patel,Gwilym J. Webb,(unknown),(unknown),(unknown),George Mells,(unknown),Simon Bowman,Francesca Barone,Benjamin A. Fisher,Gideon M. Hirschfield	45
16	Health-related quality of life and costs in Sjögren’s syndrome 2018 ·Lara D. Veeken ·Samira Tatiyama Miyamoto,Valéria Valim,Benjamin A. Fisher	47
17	B-cell activity markers are associated with different disease activity domains in primary Sjögren’s syndrome 2018 ·Lara D. Veeken ·Katherine James,(unknown),Antony R. Parker,Stephen Harding,Simon Cockell,Colin S. Gillespie,Jennifer Hallinan,Francesca Barone,Simon Bowman,Wan‐Fai Ng,Benjamin A. Fisher,(unknown)	20
18	Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren's syndrome 2018 ·Annals of the Rheumatic Diseases ·Saba Nayar,Joana Campos,Charlotte G. Smith,Valentina Iannizzotto,David H. Gardner,Serena Colafrancesco,Elena Pipi,Florian Kollert,(unknown),(unknown),Christopher D. Buckley,Simon Bowman,Roberta Priori,Guido Valesini,Maria Juárez,William A. Fahy,Benjamin A. Fisher,Andrew Payne,Rodger A. Allen,Francesca Barone	37
19	The British Society for Rheumatology guideline for the management of adults with primary Sjögren’s Syndrome 2017 ·Lara D. Veeken ·Elizabeth Price,Saaeha Rauz,Anwar R. Tappuni,Nurhan Sutcliffe,Katie L. Hackett,Francesca Barone,Guido Granata,Wan‐Fai Ng,Benjamin A. Fisher,Stefano Bombardieri,Elisa Astorri,(unknown),Genevieve Larkin,(unknown),Simon Bowman	12
20	IL-22 regulates lymphoid chemokine production and assembly of tertiary lymphoid organs 2015 ·Proceedings of the National Academy of Sciences ·Francesca Barone,Saba Nayar,Joana Campos,(unknown),David R. Withers,Kai‐Michael Toellner,Yang Zhang,Lynette A. Fouser,Benjamin A. Fisher,Simon Bowman,Javier Rangel‐Moreno,María de la Luz García-Hernández,Troy D. Randall,Davide Lucchesi,Stefano Bombardieri,Costantino Pitzalis,Sanjiv A. Luther,Christopher D. Buckley	177

About Benjamin A. Fisher

Benjamin A. Fisher is a scholar working on Periodontics, Physiology and Rheumatology, having authored 66 papers that have together received 1.6k indexed citations. Recurring topics across this work include Salivary Gland Disorders and Functions (34 papers), Salivary Gland Tumors Diagnosis and Treatment (12 papers) and Systemic Lupus Erythematosus Research (9 papers). The work is most often cited by research in Rheumatology (474 citations), Periodontics (104 citations) and Physiology (580 citations). Benjamin A. Fisher has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Francesca Barone, Simon Bowman, Christopher D. Buckley, Andrew Filer, Karim Raza, Saba Nayar, Florian Kollert, Joana Campos, Stefano Bombardieri and Iain B. McInnes. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact